A multidisciplinary spine intervention can reduce chronic back pain–related health care utilization and costs, according to a study published in Spine.
A multidisciplinary spine intervention can reduce chronic back pain (CBP)–related health care utilization and costs, according to a study published in Spine.
Worldwide, CBP is responsible for the largest number of years lived with disability and has tremendous costs, highlighting a need for interventions that will reduce the economic burden on patients and society.
The researchers examined changes in health care costs after patients with complex CBP received multidisciplinary spine care at The Groningen Spine Center (GSC) in the Netherlands. They used a before and after study design to compare health care costs 2 years before and 2 years after the intervention.
During the first visit, 2 to 4 specialists with different focus areas assessed the complaints to identify the best treatment modality and all patients received information and advice to cope. Patients who had multifactorial CBP were offered primary care treatment, such as physiotherapy or exercise or posture therapy, or outpatient interdisciplinary rehabilitation. Patients with specific CBP based on herniated disks or stenosis were offered surgery. Patients with segmental root problems were provided anesthesiology. When indicated, some patients received a combination of the interventions.
A total of 997 patients were included in the study. They received the intervention for a mean of 201 days; 546 patients received information and explanation, 203 patients followed interdisciplinary rehabilitation, 67 underwent surgery, 141 received medication or injections, and 37 received a combination intervention. There was missing information for 3 patients, and the intervention they received was not retrieved.
Health care costs related to CBP rose before the intervention and were highest during the patients' treatment at GSC but decreased in the 2 years following, to a level below the costs 1 year before the intervention. “The majority of the reduction in CBP-related health care costs appeared to be due to a reduction in medical specialist care and allied care consumption (P < .01),” the authors wrote.
In general, treatment was associated with a 34% (P < .01) reduction in CBP-related health care costs when comparing patients 1 and 2 years before the intervention with patients 1 and 2 years after the intervention. Controlling for biases found a smaller, but still significant reduction in costs. Patients with a higher baseline body mass index and female sex had a smaller reduction in CBP-related health care costs. In the adjusted sample, costs were reduced 21% (P < .01) in the 2 years after intervention compared with the 2 years before.
“This study provides complimentary evidence that multidisciplinary spine care could be cost-saving from an insurers’ perspective, whereas we found no differences between intervention types,” the authors wrote. “The results complement and point in the same direction as controlled studies, adding to the robustness of the observation that this type of care is beneficial from a health economic perspective.”
Reference
Soer R, Reneman MF, Mierau JO, et al. Can we change health care costs in patients with complex back pain?: results from a 5-year before and after study. Spine (Phila Pa 1976). 2020;45(20):1443-1450. doi:10.1097/BRS.0000000000003550
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
2 Commerce Drive
Cranbury, NJ 08512